Evidence map›Paper›PMID 40372409›Full record

ArticleBioinformatics (Oxford, England)2025

ASMC: investigating the amino acid diversity of enzyme active sites.

Thomas Bailly, Eddy Elisée, David Vallenet

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas BaillyLABGeM, Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Université Evry, Université Paris-Saclay, 91057 Evry, France.
Eddy EliséeLABGeM, Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Université Evry, Université Paris-Saclay, 91057 Evry, France.ORCID 0000-0003-2971-5782
David VallenetLABGeM, Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Université Evry, Université Paris-Saclay, 91057 Evry, France.ORCID 0000-0001-6648-0332

Funding

French National Research Agency ANR-21-ESRE-0021
6 · The paper itself

Abstract

motivationThe analysis of enzyme active sites is essential for understanding their activity in terms of catalyzed reaction and substrate specificity, providing insights for engineering to obtain targeted properties or modify the substrate scope. In 2010, a first version of the Active Site Modeling and Clustering (ASMC) workflow was published. ASMC predicts isofunctional clusters from enzyme families, based on structural modeling and clustering of active sites. Since then, structure- and sequence-based methods have developed considerably.

resultsWe present here a redesign of the ASMC workflow. This new major version includes recent pocket prediction, structural alignment and clustering methods, as well as a refined amino acid distance matrix, thereby improving the relevance of results and reducing the need for laborious manual analysis to obtain relevant clusters. In addition, we have implemented multiple sequence alignment as a possible input for the clustering step, along with an additional script to compare 2D and 3D active sites. Finally, the code has been unified from three to one programming language (Python) to facilitate its installation and maintenance. This new version of ASMC was evaluated on a set of protein families, resulting in overall better performances compared to its original version. AVAILABILITY AND IMPLEMENTATION: ASMC is supported on Linux operating system and freely available at https://github.com/labgem/ASMC, along with a complete documentation (wiki, tutorial).

Indexed as

Amino AcidsCatalytic DomainComputational BiologyEnzymesSoftwareCluster AnalysisDatabases, ProteinModels, MolecularSequence AlignmentSequence Analysis, ProteinAmino AcidsEnzymes

Identifiers

PMID40372409
PMCPMC12133276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.